March 1, 2018 / 9:52 PM / 5 months ago

BRIEF-Nektar Therapeutics Q4 Loss Per Share $0.21

March 1 (Reuters) - Nektar Therapeutics:

* REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.21

* Q4 REVENUE $95.5 MILLION VERSUS $37.5 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below